Aberdeen Group plc Has $55.72 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Key Points

• Aberdeen Group plc has reduced its position in Healthpeak Properties by 2.0%, selling 56,091 shares, thus owning 2,768,428 shares valued at approximately $55.7 million as of the last reporting period.
• Healthpeak Properties recently declared a dividend of $0.1017 per share with a current dividend payout ratio of 508.33%, signaling a high return for shareholders despite recent stock fluctuations.
• Analysts have mixed opinions on Healthpeak Properties, with target prices being adjusted downwards by several firms, while the company maintains a consensus rating of "Moderate Buy" with an average target price of $23.00.

Aberdeen Group plc cut its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 2.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,768,428 shares of the real estate investment trust's stock after selling 56,091 shares during the quarter. Aberdeen Group plc owned about 0.40% of Healthpeak Properties worth $55,715,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Invesco Ltd. lifted its position in Healthpeak Properties by 20.7% in the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock valued at $467,311,000 after acquiring an additional 3,967,830 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in shares of Healthpeak Properties by 10.6% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust's stock worth $350,021,000 after purchasing an additional 1,651,235 shares in the last quarter. Centersquare Investment Management LLC grew its holdings in Healthpeak Properties by 18.5% during the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock valued at $268,642,000 after buying an additional 2,070,416 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Healthpeak Properties by 32.6% in the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after buying an additional 2,590,530 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Healthpeak Properties by 0.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 10,392,052 shares of the real estate investment trust's stock worth $210,126,000 after acquiring an additional 76,978 shares during the last quarter. Institutional investors own 93.57% of the company's stock.

Insider Buying and Selling

In other news, Director Tommy G. Thompson purchased 5,777 shares of the stock in a transaction dated Wednesday, May 28th. The shares were bought at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the transaction, the director owned 144,290 shares in the company, valued at $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Scott M. Brinker acquired 2,930 shares of Healthpeak Properties stock in a transaction dated Thursday, July 31st. The shares were acquired at an average price of $17.06 per share, with a total value of $49,985.80. Following the transaction, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This represents a 1.41% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 14,560 shares of company stock valued at $249,898 in the last 90 days. Insiders own 0.23% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on DOC shares. Evercore ISI decreased their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Scotiabank cut shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their price target for the stock from $21.00 to $19.00 in a research report on Tuesday, July 29th. Wells Fargo & Company reduced their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Monday, June 2nd. Argus restated a "buy" rating and set a $25.00 target price on shares of Healthpeak Properties in a report on Tuesday, April 29th. Finally, Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the company an "outperform" rating in a report on Wednesday, July 30th. Seven equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $22.09.

Healthpeak Properties Price Performance

Shares of DOC traded down $0.0150 during mid-day trading on Thursday, reaching $17.2050. 1,408,586 shares of the company's stock were exchanged, compared to its average volume of 6,041,652. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The company has a 50-day simple moving average of $17.62 and a two-hundred day simple moving average of $18.42. The company has a market cap of $11.96 billion, a price-to-earnings ratio of 71.73, a PEG ratio of 2.20 and a beta of 1.05. Healthpeak Properties, Inc. has a 52-week low of $16.63 and a 52-week high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm's revenue was down .2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Monday, August 18th. This represents a dividend yield of 705.0%. Healthpeak Properties's payout ratio is 508.33%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.